Summary
Recent advances in medicine, such as cardiac catheterization, phoresis, dialysis, and cardiopulmonary bypass technology, have increased the need for heparin anticoagulation. To antagonize heparin’s effect and prevent hemorrhagic complications after the procedure, protamine has likewise been used more frequently. With its increased use have come increased reports of adverse protamine reactions consisting of rash, urticaria, elevation of pulmonary artery pressure, systemic hypotension, and, at times, death. The elevation of pulmonary artery pressure, which appears to be a rather common occurrence in animals, may be an isolated finding without clinical consequences in humans. However, this pulmonary vasoconstriction may, when severe, lead to acute right-sided heart failure and systemic hypotension. Other protamine reactions involve a decrease in systemic vascular resistance and systemic hypotension without changes in pulmonary artery pressure. Causes of acute protamine reactions may involve the generation of anaphyatoxins and prostanoids either from protamine-heparin complexes or complement-fixing antiprotamine IgG antibodies, from inhibition of plasma Carboxypeptidase N, from crosslinking of cell-surface antiprotamine IgE on mast cells and basophils with subsequent mediator release, or from potentiation of IgE-mediated release of histamine through a polycationin-recognition site.
Although we have come a long way in understanding the mechanisms by which protamine can cause its ill effects in humans, more work is clearly needed to define, in prospective studies, the incidence of and risk factors for protamine reactions in various patient groups, and to delineate more clearly which mechanisms are involved in each clinical type of acute protamine reaction. Hopefully, this will lead to strategies and protamine alternatives that will prevent or diminish, in frequency or severity, adverse protamine reactions. Alternatively, a clearer picture of the risk factors important for protamine reactions and the predictive value of diagnostic tests (e.g., protamine IgE antibody) can also minimize the clinical impact of this increasingly common adverse event.
Similar content being viewed by others
References
Horrow, J. C. (1985),Anesth. Analg. 64, 348–361.
Delange R. J. and Smith, E. L. (1979), Neurath, H. and Hill, R. L. (eds.),The Proteins, Academic, New York, pp. 119–243.
Hagedorn, H. C., Jensen, B. N., Kraup, N. B., and Woodstrup, I. (1936),JAMA 106, 177–180.
Chargaff, E. and Olson, K. B. (1937),J. Biol. Chem. 122, 153–165.
Bull, B. S., Huse, W. M., Braver, F. S., and Korpman, R. A. (1975),J. Thorac. Cardiovasc. Surg. 69, 685–689.
Sharath, M. D. Metzger, W. J., Richerson, H. B., Scupham, R. K., Meng, R. L., Ginsberg, B. H., and Weiler, J. M. (1985),J. Thorac. Cardiovasc. Surg. 90, 86–90.
Doolan, L., McKenzie, I., Krafchek, J., Parson, B., and Buxton, B. (1981),Anaesth. Intens. Care 9, 147.
Chung, F. and Miles, J. (1984),Can. Anaesth. Soc. J. 31, 314–318.
Vontz, F. K., Puestow, E. C., and Cahill, D. J., Jr. (1982),The American Surgeon 48, 549–551.
Lowenstein, E., Lynch, K., Robinson, D. R., Fitzgibbon, C. M., and Zapol, W. (1988),Am. Rev. Resp. Dis. 137(abst.), 245.
Stewart, W. J., McSweeney, S. M., Kellett, M. A., Faxon, D. P., and Ryan, T. J. (1984),Circulation 70, 788–792.
Gottschlich, G. M., Gravlee, G. P., and Georgitis, J. W. (1988),Ann. Allergy 61, 277–281.
Lakin, J. D., Blocker, T. J., Strong, D. M., and Yocum, M. W. (1977),J. Allergy Clin. Immunol. 61, 102–107.
Grant, J. A., Cooper, J. R., Albyn, K. C., Buhner, D., Farnam, J., and Yunginger, J. W. (1984),J. Allergy Clin. Immunol. 73(abst.), 180.
Gottschlich, G. M. and Georgitis, J. W. (1988),J. Allergy Clin. Immunol. 81 (abstract), 238.
Weiss, M. E., Nyhan, D., Zhikang, P., Harrow, J. C., Lowenstein, E., Hirshman, C., and Adkinson, N. F., Jr. (1989),N. Engl. J. Med. 320, 886–892.
Weiss, M. E., Chatham, F., Kagey-Sobotka, A., and Adkinson, N. F., Jr. (1990),Clinical Exper. Allergy,20, 713–720.
Morel, D. R., Zapol, W. M., Thomas, S. J., Kitain, E. M., Robinson, D. R., Moss, J., Chenoweth, D. E., and Lowenstein, E. (1987),Anesthesiol. 66, 597–604.
Knape, J. T. A., Schuller, J. L., De Haan, P., De Jong, A. P., and Bovill, J. G. (1981),Anesthesiol. 55, 324,325.
Caplan, S. N. and Berkman, E. M. (1976),N. Engl. J. Med. 295, 172.
Samuel, T., Kolk, A. H. J., Rumke, P., and Van Lis, J. M. J. (1975),Clin. Exp. Immunol. 21, 65.
Samuel, T. and Linnet, L. (1978),Clin. Exp. Immunol. 33, 261.
Samuel, T. (1977),Clin. Exp. Immunol. 30, 181.
Adourian, U., Fischer, E., Adkinson, N. F. Jr., Hirshman, C. A. (1990)Anesthesiology,73, A1257 (Abst.)
Keller, R. (1968),Int. Arch Allergy 34, 139–144.
Foreman, J. C. and Lichtenstein, L. M. (1980),Biochim. Biophys. Acta 629, 587–603.
Sauder, R. A. and Hirshman, C. A. (1989),American Rev. Resp. Dis. 139, A485.
Tobin, M. C., Karns, B. K., Anselmino, L. M., and Thomas, L. L. (1986),Molecular Immunology 23, 245–253.
Rent, R., Ertel, N., Eisenstein, R.,and Gewurz, H. (1975),J. Immunol. 114, 120–124.
Best, N., Teisner, B., Grudzinskas, J. G., and Fisher, M. M. (1983),Br. J. Anaesth. 55, 1149.
Best, N., Sinosich, M. J., Teisner, B., Grudzinskas, J. G., and Fisher, M. M. (1984),Br. J. Anaesth. 56, 339.
Kirklin, J. K., Chenoweth, D. E., Naftel, D. C., Blackstone, E. H., Kirklin, J. W., Bitran, D. D., Curd, J. G., Reves, J. G., and Samuelson, P. N. (1986),Ann. Thor. Surg. 41, 193–199.
Hamilton, R. G. and Kagey-Sobotka, A. (1983),J. Clin. Immunoassay 6, 160–171.
Hamilton, R. G. and Adkinson, N. F. Jr. (1988), Kemeny, D. M. and Challacombe, S. J., eds.)ELISA and Other Solid Phase Immunoassays., John Wiley, Chichester, pp. 57–84.
Kurtz, A. B., Gray, R. S., Markanday, S., and Nabarro, J. D. N. (1983),Diabetologia 25, 322–324.
Nell, L. J. and Thomas, J. W. (1988),Diabetes 37, 172–176.
Yancey, K. B., Hammer, C. H., Harvath, L., Renfer, L., Frank, M. M.,and Lawley, T. J. (1985),J. Clin. Invest. 75, 486–495.
Ghebrehiwet, B. (1985), Kaplan, A. P. (ed.),Allergy. Churchill Livingstone, New York, pp. 131–152.
Skidgel, R. A., Tan, F., Jackman, H., Zsigmond, E. K., and Erdos, E. G. (1988),Fed. Proc. 2(abst.), A1382.
Lowenstein, E. (1989),J. Cardio.Thor. Aesth. 3, 99–107.
Levy, J. H. (1986),Anaphylactic Reactions in Anesthesia and Intensive Care, Butterworths, Boston.
McIntyre, R. W., Flezzani, P., Knopes, K. D., Reves, J. G., and Watkins, W. D. (1986),Amer. J. Cardiol. 58, 857, 858.
Hobbhahn, J., Conzen, P. F., Zenker, B., Goetz, A. E., Peter, K., and Brendel, W. (1988),Anesth. Analg. 67, 253–260.
Degges, R. D., Foster, M. E., Dang, A. Q., and Read, R. C. (1987),Amer. J. Surg. 154, 696–699.
Morel, D. R., Lowenstein, E., Nguyenduy, T., Robinson, D. R., Repine, J. E., Chenoweth, D. E., and Zapol, W. M. (1988),Circulation Res. 62, 905–915.
Vegh, A. B., Gellhaus, M. A., Benson, P. M., Hottel, R. A., and Weiler, J. M. (1989),J. Allergy Clin. Immunol. 18(abst), 256.
Kelly, J. F., Patterson, R., Lieberman, P., Mathison, D. A., and Stevenson, D. D. (1978),J. Allergy. Clin. Immunol. 62, 181–184.
Greenberger, P. A. (1984),J. Allergy Clin. Immunol. 74, 600–605.
Mathews, K P., Hemphill, F. M., Lovell, R. G., Forsythe, W. E., and Sheldon, J. M. (1956),J. Allergy 27, 1–15.
Sciple, G. W., Knox, J. M., and Montgomery, C. H. (1959),N. Engl. J. Med. 261, 1123–1125.
Adourian, U., Adkinson, N. F., Jr., Hirshman, C. A., and Weiss, M. E. (1990),Anesthesiology 73, 328–331.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Weiss, M.E., Adkinson, N.F. Allergy to protamine. Clinical Reviews in Allergy 9, 339–355 (1991). https://doi.org/10.1007/BF02802312
Issue Date:
DOI: https://doi.org/10.1007/BF02802312